Supernus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.About SUPN
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.
SUPN Key Statistics
Stock Snapshot
The current Supernus Pharmaceuticals(SUPN) stock price is $45.61, with a market capitalization of 2.65B. The stock trades at a price-to-earnings (P/E) ratio of -90.97.
During the trading session on 2026-07-30, Supernus Pharmaceuticals(SUPN) shares reached a daily high of $46.77 and a low of $45.50. At a current price of $45.61, the stock is +0.2% higher than the low and still -2.5% under the high.
Trading volume for Supernus Pharmaceuticals(SUPN) stock has reached 462.84K, versus its average volume of 510.05K.
The stock's 52-week range extends from a low of $32.83 to a high of $59.68.
The stock's 52-week range extends from a low of $32.83 to a high of $59.68.
SUPN News
In the lead-up to its early August 2026 earnings release, Supernus Pharmaceuticals attracted attention after analysts highlighted its positive Earnings ESP and...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.